title: Drug points: prolonged cholestasis associated with irbesartan.
authors.affiliation: Princess Alexandra Hospital, Harlow, Essex CM20 1QX.
authors.forename: R
authors.initials: R
authors.lastname: Hariraj
authors.forename: E
authors.initials: E
authors.lastname: Stoner
authors.forename: S
authors.initials: S
authors.lastname: Jader
authors.forename: D M
authors.initials: DM
authors.lastname: Preston
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D000077405:Irbesartan; D008099:Liver / Q000473:pathology / Q000503:physiopathology; D008111:Liver Function Tests; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan